Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118724858B reveals high-yield synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing for global buyers.
Patent CN103319358B details a novel route for 7-aminoheptanoic acid. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Advanced Pt/Bi catalytic hydrogenation technology for m-aminoacetophenone. Delivers superior selectivity, green processing, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN105566131B reveals Pt-Bi catalyst method for m-aminoacetophenone. High selectivity, green process, scalable supply chain solution for pharmaceutical intermediates.
Advanced patent-based synthesis of Etimicin sulfate offers higher purity and yield. Discover cost-effective manufacturing and reliable supply chain solutions for antibiotic production.
Patent CN101260085A reveals a high-efficiency palladium-catalyzed asymmetric hydrogenation route for chiral gamma-sultams, offering superior enantioselectivity and scalable manufacturing advantages.
Novel four-step route for Moxifloxacin side chain reduces cost and improves supply chain reliability for global pharmaceutical manufacturing partners.
Advanced synthesis patent CN117700405B enables high-purity pharmaceutical intermediates with streamlined processes for cost reduction in API intermediate manufacturing and supply reliability.
Patent CN108658831A reveals high-yield Pd-catalyzed route for Brivaracetam intermediates. Enables cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Patent CN1301960C details a novel one-pot hydrogenation method for 2-benzylaniline, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104860870A reveals a safer, ambient-pressure method for producing high-purity piperidine derivatives, offering significant cost and supply chain advantages.
Advanced synthesis of Imipenem monohydrate via phosphorylation and condensation. Reduces impurities and enhances yield for reliable pharmaceutical intermediates supply.
Patent CN101921274A reveals a streamlined Imipenem synthesis using solvent inclusion intermediates, offering significant cost reduction and high-purity manufacturing for pharmaceutical supply chains.
Patent CN1218463A details novel asymmetric synthesis routes for elastase inhibitor intermediates, offering improved stereoselectivity and scalable manufacturing processes for pharmaceutical supply chains.
Patent CN109553513B reveals a novel 2-step route for 4-(2-methoxyethyl)phenol, offering cost-effective API intermediate manufacturing.
Patent CN100355732C reveals a novel catalytic hydrogenation route for 2-chloro-5-fluoro-nicotinic acid, offering superior yield and supply chain stability for pharmaceutical manufacturers.
Novel TiCl4-catalyzed asymmetric cyclization for high-purity spiroindane intermediates. Eliminates resolution steps, ensuring cost-effective supply for chiral ligand manufacturing.
Patent CN108101785A reveals iridium catalysis for chiral beta-hydroxy esters. Offers high ee and mild conditions for pharma supply chains. Enables cost reduction in pharmaceutical intermediates manufacturing.
Novel asymmetric reduction route for Baloxavir Marboxil isomer. Eliminates chiral resolution, reduces cost, ensures supply chain stability for pharmaceutical manufacturing.